EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Butyrate inhibits type 2 inflammation in eosinophilic chronic rhinosinusitis

Masatomo Toyama, Hideaki Kouzaki, Takeshi Shimizu, Hitoshi Hirakawa, Mikio Suzuki

Biochemical and Biophysical Research Communications · 2024

DOI: 10.1016/j.bbrc.2024.149967 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Masatomo Toyama und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, 903-0215, Japan; Departmen…. Hauptthemen laut MEDLINE: Butyrates, Cytokines, Receptors, Cell Surface, Receptors, G-Protein-Coupled. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Butyrate and other Short-chain fatty acids (SCFAs) are microbial metabolites from Bacteroides and Clostridium species that may suppress type 2 inflammation. However, the mechanisms of SCFAs in the nasal sinuses are not fully understood. We aimed to clarify the in vitro and in vivo roles of SCFAs in eosinophilic chronic rhinosinusitis (ECRS) pathophysiology. We investigated whether SCFAs induced changes in type 2 cytokines, IgE, and apoptosis and the roles of GPR41, GPR43, and histone deacetylase. Analysis of the control subjects demonstrated that butyrate of SCFAs effectively inhibited type 2 cytokine production in PBMCs, ILC2s, and CD4+ T cells and IgE production in CD19+ B cells. In annexin V analysis, butyrate also induced late apoptosis of PBMCs. The butyrate-induced inhibition of type 2 cytokines appeared involved in histone deacetylase inhibition but not in GPR41 or GPR43. In an analysis of ECRS in humans, butyrate inhibited type 2 cytokine production in PBMCs and nasal polyp-derived cells. The butyrate concentration in nasal lavage fluid was significantly decreased in ECRS patients compared to controls and non-ECRS patients. Our findings confirm that butyrate can inhibit type 2 inflammation and may be a potential therapeutic target for ECRS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ButyratesCytokinesReceptors, Cell SurfaceReceptors, G-Protein-CoupledRhinosinusitisAdultFemaleHumansMaleMiddle AgedApoptosisCells, CulturedChronic DiseaseEosinophiliaImmunoglobulin EInflammationNasal Polyps

Stichwörter der Autor:innen

AllergenButyrateChronic rhinosinusitisEosinophilShort-chain fatty acidsType 2 cytokine

Substanzen

ButyratesCytokinesFFAR2 protein, humanImmunoglobulin EReceptors, Cell SurfaceReceptors, G-Protein-Coupled

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, 903-0215, Japan; Department of Otorhinolaryngology and Head and Neck Surgery, Shiga University o…
  • Department of Otorhinolaryngology and Head and Neck Surgery, Shiga University of Medical Science, Otsu, Shiga, 520-2192, Japan.
  • Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, 903-0215, Japan.
  • Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, 903-0215, Japan. Electronic address: suzuki@med.u-ryukyu.ac.jp.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Toyama, M., Kouzaki, H., Shimizu, T., Hirakawa, H., & Suzuki, M. (2024). Butyrate inhibits type 2 inflammation in eosinophilic chronic rhinosinusitis. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.149967

Vancouver

Toyama M, Kouzaki H, Shimizu T, Hirakawa H, Suzuki M. Butyrate inhibits type 2 inflammation in eosinophilic chronic rhinosinusitis. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.149967

BibTeX
@article{Toyama2024,
  author = {Toyama, Masatomo and Kouzaki, Hideaki and Shimizu, Takeshi and Hirakawa, Hitoshi and Suzuki, Mikio},
  title = {Butyrate inhibits type 2 inflammation in eosinophilic chronic rhinosinusitis},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2024},
  doi = {10.1016/j.bbrc.2024.149967}
}
Kostenlos starten →